XML 19 R5.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY - USD ($)
$ in Thousands
Preferred Stock Series B
Preferred Stock Series C
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Total
Beginning Balance, Amount at Dec. 31, 2013 $ 1,139 $ 0 $ 0 $ 101,840 $ (132) $ (103,025) $ (107)
Beginning Balance, Shares at Dec. 31, 2013 2 0 705        
Preferred dividends           (152) (152)
Conversion of preferred stock, Amount $ (461)   $ 2 459     0
Conversion of preferred stock, Shares (1)   23        
Issuance of common stock and warrants, Amount       433     433
Issuance of stock options       61     61
Exercise of warrants and options into common stock, Amount     $ 0 96     96
Exercise of warrants and options into common stock, Shares     4        
Stock-based compensation expense       886     886
Conversion of debts into common stock, Amount     $ 3 890     893
Conversion of debts into common stock, Shares     28        
Net Loss           (9,883) (9,883)
Ending Balance, Amount at Dec. 31, 2014 $ 678 $ 0 $ 97 107,952 (132) (113,060) (4,465)
Ending Balance, Shares at Dec. 31, 2014 1 0 969        
Preferred dividends           (352) (352)
Issuance of common stock and warrants, Amount     $ 11 1,327     1,338
Issuance of common stock and warrants, Shares     106        
Conversion of Series C preferred stock to common stock, Amount   $ (840) $ 99 1,727   (986) 0
Conversion of Series C preferred stock to common stock, Shares   (2) 990        
Exercise of warrants and options into common stock, Amount     $ 11 132     143
Exercise of warrants and options into common stock, Shares     111        
Stock-based compensation expense       1,008     1,008
Conversion of debts into common stock, Amount     $ 15 999     1,014
Conversion of debts into common stock, Shares     168        
December 2014 public offering warrants exchange and common shares issuance, Amount     $ 3 1,368   (1,049) 322
December 2014 public offering warrants exchange and common shares issuance, Shares     27        
Series B, Tranche A, warrant price adjustment       64   (64) 0
Series C preferred stock and warrant issuance, Amount $ (678) $ 2,892   268   (150) 2,332
Series C preferred stock and warrant issuance, Shares (1) 8          
Net Loss           (6,902) (6,902)
Ending Balance, Amount at Dec. 31, 2015 $ 0 $ 2,052 $ 236 $ 114,845 $ (132) $ (122,563) $ (5,562)
Ending Balance, Shares at Dec. 31, 2015 0 6 2,371